OBIO marks $704m funding milestone for Canadian health tech ventures
The initiative is designed to help post-seed health science enterprises secure investment, form corporate partnerships.
The initiative is designed to help post-seed health science enterprises secure investment, form corporate partnerships.
Amid this probe, experts point to the importance of airtight AI governance when implementing the technology in high-risk contexts.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
How DFE Pharma supports confident continuous manufacturing decisions
Industry partnership will determine the success of the transition to low-GWP pMDIs
Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory
Turning AI skeptics into AI advocates through high-integrity data